Milan - Delayed Quote EUR
CureVac N.V. (1CVAC.MI)
3.1860
+0.1260
+(4.12%)
At close: May 16 at 4:11:38 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
101,851
101,851
-267,887
-286,177
-733,128
Investing Cash Flow
-18,444
-18,444
-55,200
-93,499
-127,901
Financing Cash Flow
-5,114
-5,114
230,893
63,173
344,964
End Cash Position
481,748
481,748
402,452
495,797
811,464
Capital Expenditure
-18,444
-18,444
-55,200
-93,222
-127,901
Issuance of Capital Stock
0
0
235,840
66,484
404,062
Issuance of Debt
--
--
--
0
0
Repayment of Debt
-5,114
-5,114
-5,193
-4,221
-28,183
Repurchase of Capital Stock
--
--
--
--
-30,915
Free Cash Flow
83,407
83,407
-323,087
-379,399
-861,029
12/31/2021 - 11/21/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
F6T.DU Fate Therapeutics Inc
0.9210
+0.30%
1GDA.F Zevra Therapeutics, Inc.
7.45
+4.20%
P0F.F Egetis Therapeutics AB (publ)
0.2740
-7.90%
1TB0.SG Orphazyme AS
137.50
0.00%
8GN.F Cessatech A/S
1.6640
-2.23%
41X.SG Ardelyx Inc
2.9800
-1.06%
22UA.MU BioNTech SE
83.10
+0.79%
BLUE.MX bluebird bio, Inc.
80.00
0.00%
FTD.SG Financière de Tubize SA
121.60
+1.00%
CLAZF Claritas Pharmaceuticals, Inc.
0.0001
0.00%